Portal de Periódicos da CAPES

CNS Dopamine Autoreceptors: Distribution, Pharmacology, and Function a

1984; Wiley; Volume: 430; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.1984.tb14497.x

1749-6632

Robert H. Roth,

Neuroscience and Neuropharmacology Research

Annals of the New York Academy of SciencesVolume 430, Issue 1 p. 27-53 CNS Dopamine Autoreceptors: Distribution, Pharmacology, and Functiona ROBERT H. ROTH, ROBERT H. ROTH Department of Pharmacology Yale University School of Medicine New Haven, Connecticut 06510Search for more papers by this author ROBERT H. ROTH, ROBERT H. ROTH Department of Pharmacology Yale University School of Medicine New Haven, Connecticut 06510Search for more papers by this author First published: June 1984 https://doi.org/10.1111/j.1749-6632.1984.tb14497.xCitations: 149 a Much of the research cited in this review was supported by Grants MH-14092 and MH-28849 from the U.S. Public Health Service and by grants from the State of Connecticut. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Kehr, W., A. Carlsson, M. Lindqvist, T. Magnusson & C. Atack. 1972. Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity. J. Pharm. Pharmac. 24: 744. 2 Roth, R. H., J. R. Walters & G. K. Aghajanian. 1973. Effect of impulse flow on the release and synthesis of DA in the rat striatum. In Frontiers in Catecholamine Research. S. H. Snyder & E. Costa, Eds.: 567. Pergamon Press, New York , NY . 3 Langer, S. 1973. The regulation of transmitter release elicited by nerve stimulation through a presynaptic feedback mechanism. In Frontiers in Catecholamine Research. S. H. Snyder & E. Usdin, Eds.: 543. Pergamon Press, New York , NY . 4 Farnebo, L. O. & B. Hamberger. 1971. Drug-induced changes in the release of H3-monoamines from field-stimulated rat brain slices. Acta Physiol. Scand. (Suppl.) 371: 35–44. 5 Carlsson, A. 1975. Receptor-mediated control of dopamine metabolism. In Pre- and Postsynaptic Receptors. E. Usdin & W. E. Bunney, Eds.: 49–65. Marcel Dekker. New York , NY. . 6 Aghajanian, G. K. & B. S. Bunney. 1974. In Frontiers of Neurology and Neuroscience Research. P. Seemans & G. M. Brown, Eds.: 4–11. University of Toronto Press. Toronto , Ontario , Canada . 7 Bunney, B. S. & G. K. Aghajanian. 1975, Evidence for drug actions on both pre- and postsynaptic receptors in the CNS. In Pre- and Postsynaptic Receptors. E. Usdin & W. E. Bunney, Eds. Marcel Dekker. New York , NY . 8 Nowycky, M. D. & R. H. Roth. 1977. Presynaptic dopamine receptors. Development of supersensitivity following treatment with fluphenazine decanoate. Naunyn-Schmiedeberg's Arch. Pharmacol. 300: 247–254. 9 Hjorth, S., A. Carlsson, H. Wikström, P. Lindberg, D. Sanchez, V. Hacksell, L. E. Arvidsson, V. Svensson & J. L. G. Nilsson. 1981. 3–PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptors. Life Sci. 28: 1225–1238. 10 Alander, T., N. E. Anden & M. Grabowska-Anden. 1980. Metoclopramide and sulpiride as selective blocking agents of pre- and postsynaptic dopamine receptors. Naunyn-Schmiedeberg's Arch. Pharmakol. 312: 145–150. 11 Skirboll, L. R., A. A. Grace & B. S. Bunney. 1979. Dopamine auto- and postsynaptic receptors: Electrophysiological evidence for differential sensitivity to dopamine agonists. Science 206: 80–82. 12 Roth, R. H. 1979. Dopamine autoreceptors: Pharmacology, function and comparison with postsynaptic dopamine receptors. Commun. Psychopharmacol. 3: 429–445. 13 Farnebo, L.-O. & B. Hamberger. 1973. Catecholamine release and receptors in brain slices. In Frontiers in Catecholamine Research. S. H. Snyder & E. Usdin, Eds.: 589, Pergamon Press. New York , N Y. 14 Reinmann, W., A. Zumstein, R. Jackisch, K. Starke & G. Hertting. 1979. Effect of extracellular dopamine on the release of dopamine in the rabbit caudate nucleus: Evidence for a dopaminergic feedback inhibition. Naunyn-Schmiedeberg's Arch. Pharmacol. 306: 53–60. 15 Starke, K. 1983. Functional in vitro comparisons of striatal pre- and postsynaptic dopamine receptors. In Supplement to Progress in Neuro-Psychopharmacology and Biological Psychiatry, 5th Catecholamine Symposium, Göteborg, Sweden. Pergamon Press. Oxford . 16 Christiansen, J. & R. F. Squires. 1974. Antagonistic effects of apomorphine and haloperidol on rat striatal synaptosomal tyrosine hydroxylase. J. Pharm. Pharmacol. 26: 367–369. 17 Goldstein, M., L. S. Freedman & T. Backstrom. 1970. The inhibition of catecholamine biosynthesis by apomorphine. J. Pharm. Pharmacol. 22: 715–716. 18 Westfall, T., M. Besson, M. Giorguieff & J. Glowinski. 1976. The role of presynaptic receptors in the release and synthesis of 3H-dopamine by slices of rat striatum. Naunyn-Schmiedeberg's Arch. Pharmacol. 292: 279–287. 19 Iversen, L. L., M. A. Rogawski & R. J. Miller. 1976. Comparison of the effects of neuroleptic drugs on pre- and postsynaptic dopaminergic mechanisms in the rat striatum. Mol. Pharmacol. 12: 251–262. 20 Nowycky, M. C. & R. H. Roth. 1978. Dopaminergic neurons: Role of presynaptic receptors in the regulation of transmitter biosynthesis. Prog. Neuro-Psychopharmacol. 2: 139–158. 21 Dichiara, G., M. L. Porceddu, W. Fratta & G. L. Gessa. 1977. Postsynaptic receptors are not essential for dopaminergic feedback regulation. Nature 267: 210–272. 22 Dichiara, G., M. L. Porceddu, P. F. Spano & G. L. Gessa. 1977. Haloperidol increases and apomorphine decreases striatal dopamine metabolism after destruction of striatal dopamine-sensitive adenylate cyclase by kainic acid. Brain Res. 130: 374–382. 23 Thierry, A. M., G. Blanc, A. Sobel, L. Stinus & J. Glowinski. 1973. Dopaminergic terminals in the rat cortex. Science 182: 499–501. 24 Swanson, L. W. 1982. The projections of the ventral tegmental area and adjacent regions: A combined fluorescent retrograde and immunofluorescence study in the rat. Brain Res. Bull 9: 321–354. 25 Bannon, M. J. & R. H. Roth. 1983. Pharmacology of mesocortical dopamine neurons. Pharmacol. Rev. 35: 53–68. 26 Thierry, A. M., J. P. Tassin, G. Blanc & J. Glowinski. 1978. Studies on mesocortical dopamine systems. In Advances in Biochemical Psychopharmacology. P. J. Roberts, G. N. Woodruff & L. L. Iversen, Eds. Vol. 19: 205–216. Raven Press. New York , NY . 27 Bannon, M. J., R. L. Michaud & R. H. Roth. 1981. Mesocortical dopamine neurons: Lack of autoreceptors modulating dopamine synthesis. Mol. Pharmacol. 19: 270–275. 28 Bannon, M. J., J. F. Reinhard, Jr., E. B. Bunney & R. H. Roth. 1982. Mesocortical dopamine neurons: Unique response to antipsychotic drugs explained by the absence of terminal autoreceptors. Nature 296: 444–446. 29 Tassin, J. P., J. Bockaert, G. Blanc, L. Stinus, A. M. Thierry, S. Lavielle, J. Premont & J. Glowinski. 1978. Topographical distribution of dopaminergic innervation and dopaminergic receptors of the anterior cerebral cortex of the rat. Brain Res. 154: 241–251. 30 Cooper, J. R., F. E. Bloom & R. H. Roth. 1982. The Biochemical Basis of Neuropharmacology. Oxford University Press. New York , NY . 31 Bannon, M. J., E. B. Bunney & R. H. Roth. 1981. Mesocortical dopamine neurons: Rapid transmitter turnover compared to other brain catecholamine systems. Brain Res. 218: 376–382. 32 Chiodo, L. A., M. J. Bannon, A. A. Grace, R. H. Roth & B. S. Bunney. 1983. Absence of autoreceptors on a subpopulation of mesocortical dopamine neurons: Electrophysiological and biochemical evidence. Neuroscience: In press. 33 Bannon, M. J., M. E. Wolf & R. H. Roth. 1983. Pharmacology of dopamine neurons innervating the prefrontal, cingulate and piriform cortices. Eur. J. Pharmacol. 91: 119–125. 34 Walters, J. R. & R. H. Roth. 1976. Dopaminergic neurons: An in vivo system for measuring drug interactions with presynaptic receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 296: 5–14. 35 Michaud, R. L., M. J. Bannon & R. H. Roth. 1981. The use of C8-octyl columns for the analysis of catecholamines by ion-pair reversed-phase liquid chromatography with amperiometric detection. J. Chromatogr. 225: 335–345. 36 Roth, R. H., M. J. Bannon, M. A. Wolf & M. L. Billingsley. 1983. Dopamine autoreceptors: Biochemical studies on their pharmacology, distribution and function. Acta Pharmaceutica Suecica Suppl. I: 99–107. 37 Roth R. H., P. M. Salzman & M. C. Nowycky. 1978. Impulse flow and short-term regulation of transmitter biosynthesis in central catecholaminergic neurons. In Psychopharmacology: A Generation of Progress. M. A. Lipton, A. DiMascio & K. F. Killam, Eds. Raven Press. New York , NY . 38 Bunney, B. S., J. R. Walters, R. H. Roth & G. K. Aghajanian. 1973. Dopaminergic neurons: Effect of antipsychotic drugs and amphetamine on single cell activity. J. Pharmacol. Exp. Ther. 185: 560–571. 39 Bunney, B. S. & A. A. Grace. 1978. Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activity. Life Sci. 23: 1715–1728. 40 Bunney, B. S. 1979. The electrophysiological pharmacology of midbrain dopaminergic systems. In The Neurobiology of Dopamine. A. S. Horn, J. Korf & B. H. C. Westerink, Eds.: 417–452. Academic Press. New York , NY. . 41 Scatton, B. 1977. Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration. Eur. J. Pharmacol. 46: 363–369. 42 Bannon M. J., L. A. Chiodo, E. B. Bunney, M. E. Wolf, A. A. Grace, B. S. Bunney & R. H. Roth. 1983. In vivo biochemical and electrophysiological studies on the distribution and pharmacology of dopamine autoreceptors. In Proceedings of the 5th International Catecholamine Symposium, Göteborg, Sweden. Alan R. Liss. New York , NY . In press. 43 Grace, A. A. & B. S. Bunney. 1983. Intracellular and extracellular electro-physiology of nigral dopaminergic neurons. I. Identification and characterization. Neurosciences 10: 301–315. 44 Thierry, A. M., J. P. Tassin, G. Blanc & J. Glowinski. 1976. Selective activation of the mesocortical DA system by stress. Nature 263: 242–243. 45 Fadda, F., A. Argiolas, M. R. Melis, A. H. Tissari, P. L. Onali & G. L. Gessa. 1978. Stress-induced increase in 3,4–dihydroxyphenylacetic acid (DOPAC) levels in the cerebral cortex and in n. accumbens: Reversal by diazepam. Life Sci. 23: 2219–2224. 46 Reinhard, J. F., Jr., M. J. Bannon & R. H. Roth. 1982. Acceleration by stress of dopamine synthesis and metabolism in prefrontal cortex: Antagonism by diazepam. Nauyn-Schmiedeberg's Arch. Pharmacol. 318: 374–377. 47 Lavielle, S., J. P. Tassin, A. M. Thierry, G. Blanc, D. Herve, C. Barthelemy & J. Glowinski. 1978. Blockade by benzodiazepines of the selective high increase in dopamine turnover induced by stress in mesocortical dopaminergic neurons of the rat. Brain Res. 168: 585–594. 48 Bannon, M. J., P. J. Elliot, J. E. Alpert, M. Goedert, S. D. Iversen & L. L. Iversen. 1983. Selective activation of mesocortical dopamine neurons by stress: The role of substance P afferents demonstrated using in vivo application of substance P monoclonal antibody. Nature 306: 791–792. 49 Herman, J. P., D. Guillonneau, R. Dantzer, B. Scatton, L. Semerdjian-Rouquier & M. Lemoal. 1982. Differential effects of inescapable footshocks and of stimuli previously paired with inescapable footshocks on dopamine turnover in cortical and limbic areas of the rat. Life Sci. 30: 2207–2214. 50 Scatton, B., J. Glowinski & L. Julou. 1976. Dopamine metabolism in the mesolimbic and mesocortical dopaminergic systems after single or repeated administration of neuroleptics. Brain Res. 109: 184–189. 51 Matsumoto, T., H. Uchimura, M. Hirano, J. S. Kim, H. Yokoo, M. Shimomura, T. Nakahara, K. Inoue & K. Oomagari. 1983. Differential effects of acute and chronic administration of haloperidol on homovanillic acid levels in discrete dopaminergic areas of rat brain. Eur. J. Pharmacol. 89: 27–33. 52 Julou, L., B. Scatton & J. Glowinski. 1977. Acute and chronic treatment with neuroleptics: Similarities and differences in their action on nigrostriatal, mesolimbic and mesocortical dopaminergic neurons. In Advances in Biochem. Psychopharmacology. E. Costa & G. L. Gessa, Eds. Raven Press. New York , NY . 53 Bacopoulos, N. G., G. Bustos, D. E. Redmond, J. Baulu & R. H. Roth. 1978. Regional sensitivity of primate brain dopaminergic neurons to haloperidol: Alterations following chronic treatment. Brain Res. 157: 369–401. 54 Roth, R. H., N. G. Bacopoulos, G. Bustos & D. E. Redmond. 1980. Antipsychotic drugs: Differential effects on dopamine neurons in basal ganglia and mesocortex following chronic administration in human and nonhuman primates. Adv. Biochem. Psychopharmacol. 24: 513–520. 55 Chiodo, L. A. & B. S. Bunney. 1983. Typical and atypical neuroleptics: Differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J. Neurosci. 3: 1607–1619. 56 Clark, D., A. Carlsson, S. Hjorth, K. H. Svensson, S. Liljequist, J. Engel, G. Engberg, T. H. Svensson & H. Wikstrom. 1983. Is 3-PPP a potential antipsychotic drug Acta Pharmaceutica Suecica Suppl. I: 145–153. 57 Bunney, B. S., L. T. Meltzer, J. A. Kauer & L. A. Chiodo. 1983. 3-PPP: A selective dopamine autoreceptor agonist? Electrophysiological studies. Acta Pharmaceutica Suecica Suppl. I: 138–144. 58 Chiodo, L. A. & B. S. Bunney. 1983. Electrophysiological studies on EMD 23448: A putative selective dopamine autoreceptor agonist. Neuropharmacology. 22: 1087–1093. 59 Walters, J. R., D. A. Bergstrom, S. D. Bromley, B. L. Waszczak & D. M. Jackson. 1983. Neurophysiological effects of dopamine agonists in the substantia nigra and globus pallidus. Acta Pharmaceutica Suecica Suppl. 1: 186–199. 60 Roth, R. H., J. R. Walters, L. C. Murrin & V. H. Morgenroth, III. 1975. Dopaminergic neurons: Role of impulse flow and pre-synaptic receptors in the regulation of tyrosine hydroxylase. In Pre- and Postsynaptic Receptors, E. Usdin & W. E. Bunney, Eds.: 5–58. Marcel Dekker. New York , NY. . 61 Billingsley, M. L. & R. H. Roth. 1982. Dopamine autoreceptor agonists stimulate protein carboxylmethylation in striatal synaptosomes. J. Pharmacol. Exp. Ther. 223: 681–688. 62 Wolf, M. E. & R. H. Roth. 1983. Dopamine agonists stimulate protein carboxyl methylation in striatal slices. Proc. Soc. Neurosci. 9: 1004, #291.20. 63 Means, A. R., J. S. Tash & J. G. Chafouleas. 1982. Physiological implications of the presence and distribution and regulation of calmodulin in eukaryotic cells. Physiol. Rev. 62: 1–39. 64 Delorenzo, R. J. 1980. Role of calmodulin in neurotransmitter release and synaptic function. Ann. N. Y. Acad. Sci. 356: 92–109. 65 Gagnon, C., S. Kelly, V. Manganiello, M. Vaughn, C. Odya, W. Stritt-Matter, A. Hoffman & F. Hirata. 1981. Modification of calmodulin function by enzymatic carboxyl methylation. Nature (London) 291: 515–516. 66 Hanbauer, I., S. Pradhan & H. Y. Yang. 1980. Role of calmodulin in dopaminergic transmission. Ann. N. Y. Acad. Sci. 356: 292–303. 67 Lucchelli, A., A. Guidotti & E. Costa. 1978. Striatal content of Ca2+-dependent regulator protein and dopaminergic receptor function. Brain Res. 155: 130–135. 68 Hanbauer, I., J. Gimble & W. Lovenberg. 1979. Changes in soluble calmodulin following activation of dopamine receptors in rat striatal slices. Neuropharmacology 18: 851–857. 69 Fonlupt, P., C. Rey & H. Pacheco. 1982. Phospholipid methylation and noradrenaline exchanges in a synaptosomal preparation from rat brain. J. Neurochem. 38: 1615–1620. 70 Rabe, C. S. & R. McGee, Jr. 1982. The effects of methylation inhibitors on depolarization-dependent exocytosis, phospholipid methylation, and protein carboxyl methylation in clonal pheochromocytoma cells. In The Biochemistry of S-Adenosylmethionine and Related Compounds. R. T. Borchardt, E. Usdin & C. R. Creveling, Eds. MacMillan, London . 71 Billingsley, M. L., P. A. Velletri, R. H. Roth & R. J. Delorenzo. 1983. Carboxylmethylation of calmodulin inhibits calmodulin-dependent phosphorylation in rat brain membranes and cytosol. J. Biol. Chem. 258: 5352–5357. Citing Literature Volume430, Issue1Presynaptic Modulation of Postsynaptic Modulation in Mental DiseasesJune 1984Pages 27-53 ReferencesRelatedInformation